Medical Director, Dyslipidemia

AstraZeneca•Wilmington, DE

7d•$193,282 - $289,922•Hybrid

About The Position

The Medical Director – Dyslipidemia supports the development and execution of US Medical strategy for dyslipidemia and related assets. The role translates disease area and brand priorities into actionable medical execution plans, coordinates cross-functional execution, and helps ensure medical activities align with clinical, scientific, customer, healthcare environment, and business needs. It requires understanding of the disease area and the evolving US healthcare environment, and inspiring change at scale through coordinated medical strategy, external scientific engagement, and transforming care initiatives. The role reports directly to the Medical Head – Dyslipidemia, within the BioPharmaceuticals Business Unit’s US Medical CVRM franchise. The position is based in Wilmington, Delaware, with a hybrid schedule requiring an average minimum of three days per week in the office. The annual base pay range is $193,281.60–$289,922.40, with a short-term incentive bonus opportunity and eligibility to participate in an equity-based long-term incentive program. Benefits include a qualified retirement program (401(k)), paid vacation and holidays, paid leaves, and medical, prescription drug, dental, and vision coverage, subject to plan terms and conditions.

Requirements

MD, PhD, or PharmD.
Medical, clinical, or scientific understanding of CVRM and dyslipidemia, with the ability to apply disease area knowledge to medical planning, external engagement, and execution.
At least 3 years of experience in the pharmaceutical industry, ideally in Medical Affairs, Evidence Generation, HEOR, Clinical Development, or a relevant medical or healthcare field.
Strategic and goal-oriented thinking, with the ability to translate complex medical priorities into clear plans, deliverables, and approaches that inspire change at scale.
Demonstrated track record delivering results in a complex matrix environment and supporting impactful medical initiatives.
Ability to collaborate and build internal and external networks.
Strong analytical mindset and ability to assess large amounts of information quickly and distill it into key messages, implications, and actions.
Persuasive oral and written communication skills, including the ability to develop and deliver impactful presentations.
Demonstrated understanding of the healthcare environment and how to create change through cross-functional partnership, external engagement, and scalable medical initiatives.
Ability to collaborate with people of diverse experience and backgrounds across functions, company levels, and external organizations to deliver on goals.
Strong business acumen and understanding of the US healthcare environment, key pharmaceutical industry regulations, and how medical initiatives can help transform care.

Nice To Haves

Experience or appreciation of product launches, launch readiness, and product lifecycle management.

Responsibilities

Lead the development, delivery, and evolution of disease area and brand medical execution strategies and plans.
Identify external insights, customer needs, healthcare environment trends, and opportunities to transform care to inform medical planning and execution.
Lead the development and execution of scalable and sustainable transforming care initiatives aligned with disease area and medical strategic priorities.
Identify and advance opportunities to accelerate adoption of evidence-based care through partnerships with healthcare systems, scientific societies, quality organizations, and other external collaborators.
Coordinate cross-functional medical initiatives across Medical Affairs, Commercial, HEOR, Market Access, R&D, Field Medical, and other partners to ensure aligned execution and enable large-scale change in care delivery.
Maintain and strengthen key External Scientific Engagement relationships across healthcare systems and other collaborators to advance disease area priorities, scientific exchange, and transforming care objectives.
Support the planning and implementation of product and disease area Advisory Boards, including objective development, collaborator engagement, insight generation, and follow-up action planning.
Contribute to publication plans, evidence generation initiatives, medical education activities, and scientific communication deliverables.
Partner with Senior Medical Directors and cross-functional teams to provide medical input for regulatory and labeling activities, preparation for product introduction, and lifecycle management.